NCT03008512 2021-02-04A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of SorafenibGachon University Gil Medical CenterPhase 2 Terminated5 enrolled
NCT00882973 2017-05-05Trial to Determine the Maximum Tolerated Dose of Genexol-PM Plus Gemcitabine and Evaluate Efficacy and Safety of Genexol-PM Regimens in Subjects With Advanced Pancreatic CancerSamyang Biopharmaceuticals CorporationPhase 1 Completed18 enrolled
NCT00111904 2011-12-14Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic CancerNational Cancer Institute (NCI)Phase 2 Completed43 enrolled